The AGM adopted the financial statements and the consolidated financial statements and granted the Company's Board of Directors and the President and CEO discharge from liability for the financial period
The AGM approved the Company's Remuneration Report in the advisory vote.
Dividend
The AGM decided to pay dividends of
Resolution to authorize the Board of Directors to resolve upon an extra distribution of funds
The AGM resolved to authorize the Board of Directors of
Remuneration of members of the Board of Directors
The AGM decided in accordance with the proposal of the Shareholders' Nomination Board that the same fixed annual remuneration be paid to the members of the Board of Directors as in the previous term. The remuneration to be paid would be calculated pro rata to the length of the term of office based on the following annual remuneration:
- Chair of the Board:
EUR 115,000 -
Vice-Chair of the Board:
EUR 65,000 -
Other members of the Board of Directors:
EUR 50,000 each
It was further decided in accordance with the proposal of the Shareholders' Nomination Board that an additional annual remuneration be paid to the members of the Board of Directors that are elected as members of the Audit Committee and the
- Chair of the Audit Committee:
EUR 15,000 -
Members of the Audit Committee:
EUR 7,500 each -
Chair of the Remuneration Committee:
EUR 7,500 -
Members of the Remuneration Committee:
EUR 3,750 each
It was further decided in accordance with the proposal of the Shareholders' Nomination Board that a meeting fee in the amount of
- a fee of
EUR 800 be paid to the members of the Board that reside in the Nordic countries -
a fee of
EUR 1,600 be paid to the members of the Board that reside in other European countries -
a fee of
EUR 3,200 be paid to the members of the Board that reside outsideEurope .
The fixed annual remuneration and the meeting fees will be paid in cash. Possible travel expenses will be reimbursed according to the travel policy of the Company.
Composition of the Board of Directors
The AGM decided, in accordance with the proposal of the Shareholders' Nomination Board, that the number of members of the Board of Directors shall be six.
In accordance with the proposal of the Shareholders' Nomination Board, the AGM re-elected
Members of the Board of Directors are presented in more detail on
Election of Auditor and their remuneration
In accordance with the proposal of the Board of Directors, the AGM resolved to re-elect
Authorizing the Board of Directors to decide on the repurchase of the Company's own shares
The AGM decided, in accordance with proposal of the Board of Directors, to authorize the Board of Directors to decide on the repurchase of the Company's own shares as follows.
The number of own shares to be repurchased shall not exceed 5,000,000 shares, which corresponds to approximately 3.3 percent of all the shares in the Company. Own shares can be repurchased also otherwise than in proportion to the shareholdings of the shareholders (directed repurchase). Own shares can be repurchased using the unrestricted equity of the Company at a price formed in public trading on the date of the repurchase or otherwise at a market-based price.
Shares may be repurchased in order to develop the Company's capital structure, in order to finance or carry out acquisitions, investments or other business transactions, or in order to use the shares as part of the Company's incentive schemes.
The repurchased own shares may be held by the Company, cancelled, or transferred further.
The Board of Directors was authorized to decide on all other matters related to the repurchase of own shares. The authorization is effective until
Authorizing the Board of Directors to decide on the issuance of shares and the issuance of special rights entitling to shares
In accordance with the proposal by the Board of Directors, the AGM authorized the Board of Directors to decide on the issuance of shares as well as the issuance of special rights entitling to shares referred to in Chapter 10, Section 1 of the Companies Act as follows.
The number of shares to be issued either directly or on the basis of special rights entitling to shares shall not exceed 15,000,000 shares in aggregate, which corresponds to approximately 10 percent of all of the shares in the Company.
The Board of Directors decides on all the conditions of the issuance of shares and of special rights entitling to shares. The authorization concerns both the issuance of new shares as well as the transfer of treasury shares. The issuance of shares and of special rights entitling to shares may be carried out in deviation from the shareholders' pre-emptive rights (directed issue).
The authorization is effective until
Minutes of the AGM
The minutes of the AGM will be available on the Company's website at the address www.neles.com/agm on
Vantaa,
For more information, please contact:
Elisa Erkkilä, General Counsel,
www.neles.com, Twitter.com/nelesflow
https://news.cision.com/neles-oyj/r/decisions-by-neles-corporation-s-annual-general-meeting-2022,c3529675
(c) 2022 Cision. All rights reserved., source